BIOMEA FUSION INC
BMEA · NASDAQ
Updated at 2026-10-15 05:47:30
- Today's High
- $0.99
- Today’s Low
- $0.80
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.99
- Previous Close
- $0.83
- Volume
- 11.53M
- Market Cap
- $60.45M
- P/E Ratio
- --
- EPS
- $-0.49
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 1599 INDUSTRIAL ROAD, SAN CARLOS, CA, UNITED STATES, 94070
- Country
- US
- Listing Date
- 2021-04-16
- Fiscal Year End
- December
- Shares Outstanding
- 72.3M
- CIK
- 0001840439
- Website
- www.biomeafusion.com
Biomea Fusion, Inc., a biopharmaceutical company, is focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company is headquartered in Redwood City, California.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$12.76M
2026-03-31
$12.72M
2025-12-31
$11.67M
2025-09-30
$20.8M
Net Income
2026-06-30
-$8.32M
2026-03-31
-$12.41M
2025-12-31
$4.61M
2025-09-30
-$16.4M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.12
2026-03-31
$-0.17
2025-12-31
$-0.11
2025-09-30
$-0.24
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$8.3M
2026-03-31
-$12.36M
2025-12-31
$4.65M
2025-09-30
-$18.17M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $12.76M | $12.72M | $11.67M | $20.8M |
| Net Income | -$8.32M | -$12.41M | $4.61M | -$16.4M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.12 | $-0.17 | $-0.11 | $-0.24 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$8.3M | -$12.36M | $4.65M | -$18.17M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.